CO-FOUNDER & MANAGING PARTNER
Berlin Office »
Phone: +49 30 814 871 26
Dipl.-Ing. Friedrich-W. Gause has held various management and executive positions in Schering AG, Intendis GmbH and Bayer Healthcare both in Germany and Asia/Pacific. His professional experience comprises assignments in finance, strategic marketing and sales, business development & licensing, market access and general management, primarily associated with Rx pharmaceuticals, in vivo diagnostics and medical devices for oncology, neurology and dermatology. He guided the spin-off of Schering’s Dermatology business, led Intendis' Dermatology operations in Germany, and co-led the work-stream for Marketing & Sales integration after Bayer’s acquisition of Schering.
For more than 8 years Friedrich has worked in Asia, leading the build-out of the Medical Marketing and Sales functions of Schering’s Pharma Joint-Venture in China and as the Country Division Head Bayer Healthcare and Senior Bayer Representative and in Korea. He also chaired the Pharmaceutical Committee of the EU Chamber of Commerce in Korea (EUCCK) and served as a Vice-Chair of the Korean Research-based Pharmaceutical Industry Association (KRPIA).
From 2013 to 2015, Friedrich served as interim COO of the molecular imaging startup Piramal Imaging, where he has driven the buildup of the commercial organization and distribution network in the US, Europe and Asia/Pacific as well as the launch of Piramal’s lead product NeuraceqTM.
Friedrich-W. Gause holds a Dipl.-Ing. degree in chemical engineering and business administration from the Technische Universität Berlin.
Healthcare in the next ten years: Challenges and solutions. BGM Associates Healthcare Roundtable Report, 2014
EUCCK 2011 Market Access Issues – Position Paper Healthcare: Pharmaceuticals Committee. Website of The European Union Chamber of Commerce in Korea, www.eucck.org/site/publications
Korea – EU FTA to put Seoul at Public Health Crossroads. Interview Article in Korea Herold, July 8 2011
KGCCI Economic Outlook 2011 – The Pharmaceutical and Petro-Chemical Markets. Symposium of the Korean-German Chamber of Commerce and Industry, Seoul, January 24, 2011
Korea-EU FTA and Corporate Strategy in the Globalization Era, Compliance Framework in the Medical Industry –The Company Perspective. Session Moderator and Panelist, Seoul December 8, 2010
Strategies and Cooperation for Bio-Economy in Asia – The Industry Perspective. Panel Discussion at Korea Bio-Economy Forum, Seoul, May 26, 2010
Preisbestimmung und -administration erstattungsfaehiger Arzneimittel in Korea. Kompakt - Beitrag in KGCCI / KORUM Nr. 6, Dezember 2009